| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | President &CSO
1 company
Shacham Sharon is a Chief Scientific Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $8.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 12,500 | $15.75 | $196,832.35 | -0.9% | |
| Sep 18, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $18.26 | $182,615.00 | -1.9% | |
| Sep 7, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 12,500 | $19.31 | $241,383.75 | -1.7% | |
| Aug 20, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $17.46 | $174,568.00 | -1.9% | |
| Aug 7, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 12,500 | $18.04 | $225,556.25 | -1.7% | |
| Jul 18, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $18.27 | $182,686.00 | -1.9% | |
| Jul 9, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 12,500 | $18.72 | $233,990.00 | -1.7% | |
| Jun 18, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $18.66 | $186,558.00 | -1.9% | |
| Jun 7, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $17.30 | $172,991.00 | -1.4% | |
| May 18, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $19.39 | $193,870.00 | -1.9% |